Apr 17 |
Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?
|
Apr 5 |
Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions
|
Apr 2 |
Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 30 |
Xeris Biopharma: Checking-In On One Of My 'Top Ideas'
|
Mar 28 |
Xeris gains as Oppenheimer highlights drug technology
|
Mar 9 |
Here's What Analysts Are Forecasting For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) After Its Annual Results
|
Mar 7 |
Xeris Biopharma Holdings Inc (XERS) Reports Robust Revenue Growth in Q4 and Full Year 2023
|
Mar 7 |
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript
|
Mar 7 |
Q4 2023 Xeris Biopharma Holdings Inc Earnings Call
|
Mar 6 |
Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript
|